Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Breast Cancer Patients With Prediabetes During Neoadjuvant Chemotherapy
ChiCTR-IPR-16008553Phase 4Not yet recruiting
- Sponsor
- Department of Endocrine and Breast Surgery, First Affiliated Hospital of Chongqing Medical University
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in breast cancer and prediabetes comparing Placebo + neoadjuvant chemotherapy with Metformin + neoadjuvant chemotherapy (2 arms). Primary endpoint: Pathologic complete response. Planned start Jun 2016; status: not yet recruiting.
02
Drugs
metformin
03
Conditions
breast cancerprediabetes
Beyond the preview
Go deeper on ChiCTR-IPR-16008553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008553.